CLINIPACE, INC. CHOSEN BY MEDICAL CARBON RESEARCH INSTITUTE TO SUPPORT LANDMARK HEART VALVE RESEARCH
Clinipace, Inc., a software company focused on late-stage clinical research studies and patient registries today announced its newest client, Medical Carbon Research Institute, a biomaterials and medical device manufacturer based in Austin, Texas. Medical Carbon Research Institute (MCRI) will use Clinipace's clinical data capture and trial management technology, Tempo, to run its Phase IV study on the company's principal product - the On-X Prosthetic Heart Valve.
Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=40489)